Kazuo Fujihara

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum”.

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum

Multiple Sclerosis Journal(2023)10.1177/13524585231172145

N/A

0.373DataRank · unranked

11 citations

Dean M. Wingerchuk, Ari Green, Jeffrey L. Bennett, Ho Jin Kim, Sean J Pittock +14 more

Myelin-oligodendrocyte glycoprotein antibody-associated disease

The Lancet Neurology(2021)10.1016/s1474-4422(21)00218-0

N/A

0DataRank · unranked

519 citations

Yael Hacohen, Álvaro Cobo‐Calvo, Anne‐Katrin Pröbstel, Orhan Aktaş, Harry Alexopoulos +36 more

A Response to: Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”

Neurology and Therapy(2022)10.1007/s40120-022-00378-0

N/A

0DataRank · unranked

2 citations

Ina Zhang, Adrian Kielhorn, Minying Royston, Michael Levy, Kazuo Fujihara +5 more

SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab

Frontiers in Neurology(2023)10.3389/fneur.2023.1114667

N/A

0DataRank · unranked

6 citations

Kazuo Fujihara, Ho Jin Kim, Romain Marignier, Kevin C. O’Connor, Robert C. Sergott +11 more

Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects

Multiple Sclerosis Journal(2023)10.1177/13524585231200720

N/A

0DataRank · unranked

3 citations

Mads Nikolaj Olesen, Martin Wirenfeldt, Sören Möller, Tatsuro Misu, Kerstin Soelberg +18 more

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria

The Lancet Neurology(2025)10.1016/s1474-4422(25)00270-4

N/A

0DataRank · unranked

327 citations

Christine Lebrun‐Frénay, Jiwon Oh, Georgina Arrambide, Marcello Moccia, Maria Pia Amato +51 more